Source and scope
This summary is bounded to the recommendations, population and decisions covered by Heart failure guideline programme. Apply it with the current provincial or territorial pathway where implementation differs.
sources for this section:CCS HF
Source-attributed clinical priorities
- Stabilize oxygenation and perfusion while identifying congestion and a precipitating cause.
- Use diuresis and other acute therapies according to blood pressure, volume phenotype, renal function and the CCS pathway.
- Before discharge, reconcile disease-modifying therapy, provide self-management instructions and arrange early follow-up.
- Identify and treat the precipitant while relieving congestion and protecting perfusion.
sources for this section:CCS HF
Practical assessment and management workflow
1
Assess airway, oxygenation, perfusion, congestion, ECG, troponin, kidney function and natriuretic peptide.
2
Classify wet or dry and warm or cold phenotype and identify ACS, arrhythmia, infection or medication cause.
3
Give phenotype-directed diuresis and support and involve critical or specialist care when needed.
4
Before discharge, transition to oral treatment, optimize disease-modifying care and arrange early review.
sources for this section:CCS HF
Safety, red flags and urgent escalation
- Escalate cardiogenic shock, respiratory failure, ongoing ischemia or malignant arrhythmia.
- Monitor urine output, electrolytes and renal function during active diuresis.
- Avoid reflex fluid boluses when pulmonary congestion and elevated filling pressure are likely.
sources for this section:CCS HF
Confirm the local pathway before acting
The evidence source is pan-Canadian, but formularies, funded access, referral routes, public-health directions and service availability remain provincial or territorial.
sources for this section:CCS HF
Source and implementation boundary
Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:CCS HF
Source documents
Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.
- Canadian Cardiovascular SocietyHeart failure guideline programmeaccessed 2026-08-20view source
continue the learning
From guidance to deliberate practice and evidence
Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.
Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the Canada question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.